Global and United States Osteoarthritis Pain Drugs In-Depth Research Report 2017-2022

August 2017 | 113 pages | ID: G9D19AB4D00EN
US Market Insights (UMI)

Abstracts

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Breast Biopsy Devices industry.

Major Companies

• Mammotome (U.S.)
• Hologic (U.S.)
• C.R Bard (U.S.)
• Stryker (U.S.)
• Galini SRL (Italy)
• Medtronic (U.S.)

Key Regions

• North America
• United States
• California
• Texas
• New York
• Others
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Main types of products

Breast Biopsy Devices Market, by Product

• Biopsy Needles
• Biopsy Tables
• Guidance Systems
• Localization Wires
• Others

Breast Biopsy Devices Market, by Guidance Technique

• Ultrasound-guided Biopsy
• Stereotactic-guided Biopsy
• MRI-guided Biopsy
• Others

Breast Biopsy Devices Market, by Key Consumers

• Hospitals
• Academic and Research Institutes
• Diagnostic and Imaging Centers

Contents

CHAPTER ONE GLOBAL OSTEOARTHRITIS PAIN DRUGS MARKET OVERVIEW

1.1 Global Osteoarthritis Pain Drugs Market Sales Volume Revenue and Price 2012-2017
1.2 Osteoarthritis Pain Drugs, by Usage Mode 2012-2017
  1.2.1 Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode 2012-2017
  1.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode 2012-2017
  1.2.3 Global Osteoarthritis Pain Drugs Price by Usage Mode 2012-2017
  1.2.4 Oral
  1.2.5 Injection
  1.2.6 External
1.3 Osteoarthritis Pain Drugs, by Form 2012-2017
  1.3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Form 2012-2017
  1.3.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Form 2012-2017
  1.3.3 Global Osteoarthritis Pain Drugs Price by Form 2012-2017
  1.3.4 Tablets
  1.3.5 Ointment
  1.3.6 Spray

CHAPTER TWO UNITED STATES OSTEOARTHRITIS PAIN DRUGS MARKET OVERVIEW

2.1 United States Osteoarthritis Pain Drugs Market Sales Volume Revenue and Price 2012-2017
2.2 Osteoarthritis Pain Drugs, by Usage Mode 2012-2017
  2.2.1 United States Osteoarthritis Pain Drugs Sales Market Share by Usage Mode 2012-2017
  2.2.2 United States Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode 2012-2017
  2.2.3 United States Osteoarthritis Pain Drugs Price by Usage Mode 2012-2017
  2.2.4 Oral
  2.2.5 Injection
  2.2.6 External
2.3 Osteoarthritis Pain Drugs, by Form 2012-2017
  2.3.1 United States Osteoarthritis Pain Drugs Sales Market Share by Form 2012-2017
  2.3.2 United States Osteoarthritis Pain Drugs Revenue Market Share by Form 2012-2017
  2.3.3 United States Osteoarthritis Pain Drugs Price by Form 2012-2017
  2.3.4 Tablets
  2.3.5 Ointment
  2.3.6 Spray

CHAPTER THREE OSTEOARTHRITIS PAIN DRUGS BY REGIONS 2012-2017

3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Regions 2012-2017
3.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Regions 2012-2017
3.3 Global Osteoarthritis Pain Drugs Price by Regions 2012-2017
3.4 North America
  3.4.1 United States
    3.4.1.1 California
    3.4.1.2 Texas
    3.4.1.3 New York
    3.4.1.4 Others in United States
  3.4.2 Canada
3.5 Latin America
  3.5.1 Mexico
  3.5.2 Brazil
  3.5.3 Argentina
  3.5.4 Others in Latin America
3.6 Europe
  3.6.1 Germany
  3.6.2 United Kingdom
  3.6.3 France
  3.6.4 Italy
  3.6.5 Spain
  3.6.6 Russia
  3.6.7 Netherland
  3.6.8 Others in Europe
3.7 Asia & Pacific
  3.7.1 China
  3.7.2 Japan
  3.7.3 India
  3.7.4 Korea
  3.7.5 Australia
  3.7.6 Southeast Asia
    3.7.6.1 Indonesia
    3.7.6.2 Thailand
    3.7.6.3 Philippines
    3.7.6.4 Vietnam
    3.7.6.5 Singapore
    3.7.6.6 Malaysia
    3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
  3.8.1 South Africa
  3.8.2 Egypt
  3.8.3 Turkey
  3.8.4 Saudi Arabia
  3.8.5 Iran
  3.8.6 Others in Africa & Middle East

CHAPTER FOUR GLOBAL OSTEOARTHRITIS PAIN DRUGS BY COMPANIES 2012-2017

4.1 Global Osteoarthritis Pain Drugs Sales Volume Market Share by Companies 2012-2017
4.2 Global Osteoarthritis Pain Drugs Revenue Share by Companies 2012-2017
4.3 Global Top Companies Osteoarthritis Pain Drugs Key Product Model and Market Performance
4.4 Global Top Companies Osteoarthritis Pain Drugs Key Target Consumers and Market Performance

CHAPTER FIVE UNITED STATES OSTEOARTHRITIS PAIN DRUGS BY COMPANIES 2012-2017

5.1 United States Osteoarthritis Pain Drugs Sales Volume Market Share by Companies 2012-2017
5.2 United States Osteoarthritis Pain Drugs Revenue Share by Companies 2012-2017
5.3 United States Top Companies Osteoarthritis Pain Drugs Key Product Model and Market Performance
5.4 United States Top Companies Osteoarthritis Pain Drugs Key Target Consumers and Market Performance

CHAPTER SIX GLOBAL OSTEOARTHRITIS PAIN DRUGS BY CONSUMER 2012-2017

6.1 Global Osteoarthritis Pain Drugs Sales Market Share by Consumer 2012-2017
6.2 Medical Care
6.3 Personal Care
6.4 Other
6.5 Consuming Habit and Preference

CHAPTER SEVEN GLOBAL OSTEOARTHRITIS PAIN DRUGS BY CONSUMER 2012-2017

7.1 Global Osteoarthritis Pain Drugs Sales Market Share by Consumer 2012-2017
7.2 Medical Care
7.3 Personal Care
7.4 Other
7.5 Consuming Habit and Preference

CHAPTER EIGHT TOP COMPANIES PROFILE

8.1 Johnson & Johnson (US)
  8.1.1 Johnson & Johnson (US) Company Details and Competitors
  8.1.2 Johnson & Johnson (US) Key Osteoarthritis Pain Drugs Models and Performance
  8.1.3 Johnson & Johnson (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.1.4 Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.2 Pfizer (US)
  8.2.1 Pfizer (US) Company Details and Competitors
  8.2.2 Pfizer (US) Key Osteoarthritis Pain Drugs Models and Performance
  8.2.3 Pfizer (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.2.4 Pfizer (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.3 GlaxoSmithKline (UK)
  8.3.1 GlaxoSmithKline (UK) Company Details and Competitors
  8.3.2 GlaxoSmithKline (UK) Key Osteoarthritis Pain Drugs Models and Performance
  8.3.3 GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.3.4 GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.4 Mylan (US)
  8.4.1 Mylan (US) Company Details and Competitors
  8.4.2 Mylan (US) Key Osteoarthritis Pain Drugs Models and Performance
  8.4.3 Mylan (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.4.4 Mylan (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.5 Lilly (US)
  8.5.1 Lilly (US) Company Details and Competitors
  8.5.2 Lilly (US) Key Osteoarthritis Pain Drugs Models and Performance
  8.5.3 Lilly (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.5.4 Lilly (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.6 Sanofi (France)
  8.6.1 Sanofi (France) Company Details and Competitors
  8.6.2 Sanofi (France) Key Osteoarthritis Pain Drugs Models and Performance
  8.6.3 Sanofi (France) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.6.4 Sanofi (France) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.7 Abbott Laboratories (US)
  8.7.1 Abbott Laboratories (US) Company Details and Competitors
  8.7.2 Abbott Laboratories (US) Key Osteoarthritis Pain Drugs Models and Performance
  8.7.3 Abbott Laboratories (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.7.4 Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.8 Bayer (Germany)
  8.8.1 Bayer (Germany) Company Details and Competitors
  8.8.2 Bayer (Germany) Key Osteoarthritis Pain Drugs Models and Performance
  8.8.3 Bayer (Germany) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.8.4 Bayer (Germany) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.9 Almatica Pharma (US)
  8.9.1 Almatica Pharma (US) Company Details and Competitors
  8.9.2 Almatica Pharma (US) Key Osteoarthritis Pain Drugs Models and Performance
  8.9.3 Almatica Pharma (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.9.4 Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.10 Teva Pharmaceutical Industries (Israel)
  8.10.1 Teva Pharmaceutical Industries (Israel) Company Details and Competitors
  8.10.2 Teva Pharmaceutical Industries (Israel) Key Osteoarthritis Pain Drugs Models and Performance
  8.10.3 Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
  8.10.4 Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
8.11 Iroko Pharmaceuticals (US)

CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN

9.1 Osteoarthritis Pain Drugs Industry Chain Structure
  9.1.1 R&D
  9.1.2 Raw Materials (Components)
  9.1.3 Manufacturing Plants
  9.1.4 Regional Trading (Import Export and Local Sales)
  9.1.5 Online Sales Channel
  9.1.6 Offline Channel
  9.1.7 End Users
9.2 Osteoarthritis Pain Drugs Manufacturing
  9.2.1 Key Components
  9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment

CHAPTER TEN GLOBAL OSTEOARTHRITIS PAIN DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
10.3 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
10.4 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
10.5 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)

CHAPTER ELEVEN UNITED STATES OSTEOARTHRITIS PAIN DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 United States Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
11.3 United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
11.4 United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
11.5 United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)

CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION

12.1 Development Trend
12.2 Research Conclusion

CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Table Global Osteoarthritis Pain Drugs Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Osteoarthritis Pain Drugs Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Usage Mode (2012-2017)
Table Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode (2012-2017)
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode in 2016
Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Usage Mode (2012-2017)
Table Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode (2012-2017)
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode in 2016
Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Usage Mode (2012-2017)
Table Top Companies of Oral Osteoarthritis Pain Drugs Products List
Figure Global Oral Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of Injection Osteoarthritis Pain Drugs Products List
Figure Global Injection Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of External Osteoarthritis Pain Drugs Products List
Figure Global External Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Form (2012-2017)
Table Global Osteoarthritis Pain Drugs Sales Market Share by Form (2012-2017)
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Form in 2016
Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Form (2012-2017)
Table Global Osteoarthritis Pain Drugs Revenue Market Share by Form (2012-2017)
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Form in 2016
Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Form (2012-2017)
Table Top Companies of Tablets Osteoarthritis Pain Drugs Products List
Figure Global Tablets Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of Ointment Osteoarthritis Pain Drugs Products List
Figure Global Ointment Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of Spray Osteoarthritis Pain Drugs Products List
Figure Global Spray Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Osteoarthritis Pain Drugs Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table United States Osteoarthritis Pain Drugs Sales (K Pcs) by Usage Mode (2012-2017)
Table United States Osteoarthritis Pain Drugs Sales Market Share by Usage Mode (2012-2017)
Figure United States Osteoarthritis Pain Drugs Sales Market Share by Usage Mode in 2016
Table United States Osteoarthritis Pain Drugs Revenue (Million USD) by Usage Mode (2012-2017)
Table United States Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode (2012-2017)
Figure United States Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode in 2016
Table United States Osteoarthritis Pain Drugs Price (USD/Pcs) by Usage Mode (2012-2017)
Table Top Companies of Oral Osteoarthritis Pain Drugs Products List
Figure United States Oral Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of Injection Osteoarthritis Pain Drugs Products List
Figure United States Injection Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of External Osteoarthritis Pain Drugs Products List
Figure United States External Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table United States Osteoarthritis Pain Drugs Sales (K Pcs) by Form (2012-2017)
Table United States Osteoarthritis Pain Drugs Sales Market Share by Form (2012-2017)
Figure United States Osteoarthritis Pain Drugs Sales Market Share by Form in 2016
Table United States Osteoarthritis Pain Drugs Revenue (Million USD) by Form (2012-2017)
Table United States Osteoarthritis Pain Drugs Revenue Market Share by Form (2012-2017)
Figure United States Osteoarthritis Pain Drugs Revenue Market Share by Form in 2016
Table United States Osteoarthritis Pain Drugs Price (USD/Pcs) by Form (2012-2017)
Table Top Companies of Tablets Osteoarthritis Pain Drugs Products List
Figure United States Tablets Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of Ointment Osteoarthritis Pain Drugs Products List
Figure United States Ointment Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Top Companies of Spray Osteoarthritis Pain Drugs Products List
Figure United States Spray Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
Table Global Osteoarthritis Pain Drugs Sales Share by Regions (2012-2017)
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Regions in 2016
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Regions in 2017
Table Global Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Osteoarthritis Pain Drugs Revenue Market Share by Regions (2012-2017)
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2016
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2017
Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Regions (2012-2017)
Table North America Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
Table North America Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
Figure North America Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table United States Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
Table United States Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
Figure United States Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Latin America Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
Table Latin America Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
Table Europe Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Europe Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Asia & Pacific Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
Table Asia & Pacific Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Africa & Middle East Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
Table Africa & Middle East Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Global Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Major Companies (2012-2017)
Table Global Osteoarthritis Pain Drugs Sales Volume Market Share by Major Companies (2012-2017)
Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share by Major Companies 2016
Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share by Major Companies 2017
Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Major Companies (2012-2017)
Table Global Osteoarthritis Pain Drugs Revenue Market Share by Major Companies (2012-2017)
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Major Companies 2016
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Major Companies 2017
Table Global Top Companies Key Product Model and Market Performance
Table Global Top Companies Key Target Consumers and Market Performance
Table United States Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Top Companies (2012-2017)
Table United States Osteoarthritis Pain Drugs Sales Volume Market Share by Top Companies (2012-2017)
Figure United States Osteoarthritis Pain Drugs Sales Volume Market Share by Top Companies 2016
Figure United States Osteoarthritis Pain Drugs Sales Volume Market Share by Top Companies 2017
Table United States Osteoarthritis Pain Drugs Revenue (Million USD) by Top Companies (2012-2017)
Table United States Osteoarthritis Pain Drugs Revenue Market Share by Top Companies (2012-2017)
Figure United States Osteoarthritis Pain Drugs Revenue Market Share by Top Companies 2016
Figure United States Osteoarthritis Pain Drugs Revenue Market Share by Top Companies 2017
Table United States Top Companies Key Product Model and Market Performance
Table United States Top Companies Key Target Consumers and Market Performance
Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Consumer (2012-2017)
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Consumer (2012-2017)
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Consumer in 2016
Figure Global Medical Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Personal Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Other Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table United States Osteoarthritis Pain Drugs Sales (K Pcs) by Consumer (2012-2017)
Figure United States Osteoarthritis Pain Drugs Sales Market Share by Consumer (2012-2017)
Figure United States Osteoarthritis Pain Drugs Sales Market Share by Consumer in 2016
Figure United States Medical Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Personal Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Other Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Johnson & Johnson (US) Company Details and Competitors
Table Johnson & Johnson (US) Key Osteoarthritis Pain Drugs Models and Performance
Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Pfizer (US) Company Details and Competitors
Table Pfizer (US) Key Osteoarthritis Pain Drugs Models and Performance
Table Pfizer (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Pfizer (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Pfizer (US) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Pfizer (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Pfizer (US) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Pfizer (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table GlaxoSmithKline (UK) Company Details and Competitors
Table GlaxoSmithKline (UK) Key Osteoarthritis Pain Drugs Models and Performance
Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Mylan (US) Company Details and Competitors
Table Mylan (US) Key Osteoarthritis Pain Drugs Models and Performance
Table Mylan (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Mylan (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Mylan (US) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Mylan (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Mylan (US) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Mylan (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Lilly (US) Company Details and Competitors
Table Lilly (US) Key Osteoarthritis Pain Drugs Models and Performance
Table Lilly (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Lilly (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Lilly (US) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Lilly (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Lilly (US) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Lilly (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Sanofi (France) Company Details and Competitors
Table Sanofi (France) Key Osteoarthritis Pain Drugs Models and Performance
Table Sanofi (France) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Sanofi (France) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Sanofi (France) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Sanofi (France) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Sanofi (France) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Sanofi (France) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Abbott Laboratories (US) Company Details and Competitors
Table Abbott Laboratories (US) Key Osteoarthritis Pain Drugs Models and Performance
Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Bayer (Germany) Company Details and Competitors
Table Bayer (Germany) Key Osteoarthritis Pain Drugs Models and Performance
Table Bayer (Germany) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Bayer (Germany) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Bayer (Germany) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Almatica Pharma (US) Company Details and Competitors
Table Almatica Pharma (US) Key Osteoarthritis Pain Drugs Models and Performance
Table Almatica Pharma (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Almatica Pharma (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Teva Pharmaceutical Industries (Israel) Company Details and Competitors
Table Teva Pharmaceutical Industries (Israel) Key Osteoarthritis Pain Drugs Models and Performance
Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
Table Iroko Pharmaceuticals (US) Company Details and Competitors
Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Osteoarthritis Pain Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
Table Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions in 2022
Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application in 2022
Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Usage Mode in 2022
Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Form in 2022
Figure United States Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure United States Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Osteoarthritis Pain Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
Table United States Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions in 2022
Table United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure United States Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application in 2022
Table United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
Figure United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
Figure United States Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Usage Mode in 2022
Table United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
Figure United States Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
Figure United States Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Form in 2022